AFYREN ingredient enables global launch of natural propionic acid skincare product

Fresenius acquires remaining stake in mAbxience

Lilly reports positive 48-week Phase 2b resu;ts for EloraTZP

Merck reports positive Phase 2b results for tulisokibart in hidradenitis suppurativa

Genentech's fenebrutinib receives FDA priority review for multiple sclerosis

Takeda reports positive Phase 3 psoriasis results for zasocitinib versus deucravacitinib

Oxurion in talks to acquire Eclevar's MedTech CRO business and assets

DBV Technologies submits FDA application for VIASKIN Peanut Patch in children

Vanda Pharmaceuticals reports positive Phase III results for HETLIOZ in Delayed Sleep-Wake Phase Disorder

AstraZeneca invests USD2bn in Summit Therapeutics to advance ADC and cancer-drug combinations

Lakewood-Amedex Biotherapeutics reports positive data for clinical candidate Nu-3 in diabetic foot ulcers

BRC Therapeutics participates in regulators' workshop advancing botanical drug development

Viking Therapeutics closes offerings of common stock and convertible senior notes

Ascletis reports positive results from ASC50 clinical study for treatment of plaque psoriasis

4basebio announces Phase I cell therapy programme partnership with TriLink